Cobenfy
Payments companies reported to CMS as associated with Cobenfy. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cobenfy, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cobenfy
These are the largest totals companies reported as associated with Cobenfy. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Reynolds | Durham, NC | Psychiatry | $215,307.45 |
| Gerald Maguire | San Juan Capistraco, CA | Psychiatry | $165,586.84 |
| Rakesh Jain | Lake Jackson, TX | Psychiatry | $161,258.66 |
| Gustavo Alva | Orange, CA | Psychiatry | $160,876.47 |
| John Miller | Exeter, NH | Psychiatry | $159,403.01 |
| Michael Saribalas | Columbus, OH | Psychiatry | $159,016.33 |
| Richard Petty | Loganville, GA | Psychiatry | $153,377.34 |
| Richard Jackson | Boca Raton, FL | Psychiatry | $152,632.78 |
| Leslie Citrome | Pomona, NY | Psychiatry | $141,288.72 |
| Manish Zinzuvadia | New York, NY | Psychiatry | $139,918.40 |
Prescribed Cobenfy?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.